Unjha Formulations Ltd.

View in App
16.27 +0.25 ▲1.6%

30 November 2023, 12:47:00 PM
Volume: 4,961

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.unjhaformulations.com
Market Cap 6.96 Cr.
Enterprise Value(EV) 7.18 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) -0.56 Trailing Twelve Months Ending 2023-09
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-09
Industry PE 38.14 Trailing Twelve Months Ending 2023-09
Book Value / Share 5.62 Trailing Twelve Months Ending 2023-09
Price to Book Value 2.76 Calculated using Price: 15.53
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 0.45 Cr. 4,480,500 Shares
FaceValue 10
About Unjha Formulations Ltd.
Unjha Formulations (U-For), incorporated in 1987, is the sister concern of Urvesh Psyllium Industries Limited. U-For is the pharmaceuticals manufacturing unit, which is going to various category of formulation like tablet, capsule, oral liquids, injectables (SVP) and powder section to manufacture ayurvedic as well as allopathy products.

Unjha Formulations Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Unjha Formulations Ltd. Performance

View details >>
1 Day
+1.56%
1 Week
-5.74%
1 Month
-6.01%
3 Month
+24.29%
6 Month
+22.98%
1 Year
+62.70%
2 Year
+65.18%
5 Year
+75.89%
10 Year
+674.76%

Unjha Formulations Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 244.18 89.75 52.48 31.18 24.22 18.57 5.55 12.35 12.22
Return on Capital Employed (%) 68.66 73.70 67.61 32.15 25.41 25.57 26.80 21.13 16.76
Return on Assets (%) 4.92 8.26 8.82 6.79 7.89 8.37 2.86 7.23 8.23

Unjha Formulations Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 0 1 1 1 2 2 2 2 2 3
Non Curr. Liab. 0
Curr. Liab. 3 2 3 3 2 2 2 1 1 2
Minority Int.
Equity & Liab. 3 3 4 4 4 4 4 3 3 5
Non Curr. Assets 1 1 1 1 1 1 1 1 1 1
Curr. Assets 2 2 2 3 3 3 2 2 2 4
Misc. Exp. not W/O 0 0 0 0
Total Assets 3 3 4 4 4 4 4 3 3 5

Unjha Formulations Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09 Rs. Cr. TTM
Net Sales 9 10 12 11 11 11 10 14 13 15
Other Income 0 0 0 0 0 0 0 0 0 0
Total Income 9 10 12 11 12 11 10 14 13 15
Total Expenditure -9 -10 -12 -11 -11 -10 -10 -14 -13 -15
PBIDT 0 0 0 0 0 1 1 1 0 0
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0
Taxation 0 0 0 0
Exceptional Items
PAT 0 0 0 0 0 0 0 0 0 0
Adjusted EPS 0 1 1 1 1 1 0 1 1 -1

Unjha Formulations Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 1 -1 0 0 0 0 0 -1 0 0
Cash Fr. Inv. 0 0 0 0 0 0 0 0 0 0
Cash Fr. Finan. 0 0 0 0 0 0
Net Change 0 0 0 0 0 0 0 -1 0 0
Cash & Cash Eqvt 1 0 0 0 0 1 1 0 0 0

Unjha Formulations Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%)
Promoter 36.92 36.92 36.92 36.92 36.92 36.92 36.92 36.92 36.92
Public 63.08 63.08 63.08 63.08 63.08 63.08 63.08 63.08 63.08
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Unjha Formulations Ltd. Announcements

View details >>
Wed, 29 Nov 2023
Publish Un- Audited Financial Results For The Second Quarter & Half Year Ended As On 30.09.2023
Regulation 33(3) of SEBI (LODR) Act 2015
Thu, 09 Nov 2023
Board Meeting Outcome for Approval Of Un-Audited Financial Results Of The Company For Quarter Ended And Half Year Ended On 30Th September 2023 And Out Come Of Board Meeting Held On 9Th November 2023
Regulation 33 of SEBI(LODR) Regulations 2015
Thu, 09 Nov 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Regu 39(3)-Details of Loss of Certificates

Unjha Formulations Ltd. Technical Scans

View details >>
Wed, 29 Nov 2023
Opening at High Opening at High
Opening at High for 2 Days Opening at High for 2 Days
High Decrease in 1 Month High Decrease in 1 Month
High Increase in 3 Months High Increase in 3 Months
High Increase in 6 Months High Increase in 6 Months

Unjha Formulations Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 288,124.14 1,210.75 +0.7%
Divi's Laboratories Ltd. 98,985.27 3,800.50 +1.9%
Cipla Ltd. 97,035.44 1,199.60 -0.2%
Dr. Reddy's Laboratories Ltd. 95,335.50 5,751.05 +0.6%
Apollo Hospitals Enterprise Ltd. 77,919.78 5,495.00 +1.4%
Mankind Pharma Ltd. 76,041.70 1,888.25 -0.6%
Torrent Pharmaceuticals Ltd. 70,779.09 2,119.20 +1.3%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 33.70 1,210.75 +0.7%
Divi's Laboratories Ltd. Consolidated 2023-09 74.33 3,800.50 +1.9%
Cipla Ltd. Consolidated 2023-09 28.10 1,199.60 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 18.73 5,751.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 111.72 5,495.00 +1.4%
Mankind Pharma Ltd. Consolidated 2023-03 59.32 1,888.25 -0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 53.06 2,119.20 +1.3%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 4.82 1,210.75 +0.7%
Divi's Laboratories Ltd. Consolidated 2023-09 7.81 3,800.50 +1.9%
Cipla Ltd. Consolidated 2023-09 3.91 1,199.60 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 3.74 5,751.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 11.99 5,495.00 +1.4%
Mankind Pharma Ltd. Consolidated 2023-03 9.02 1,888.25 -0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 10.55 2,119.20 +1.3%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,210.75 +0.7%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,800.50 +1.9%
Cipla Ltd. Consolidated 2023-03 0.02 1,199.60 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,751.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,495.00 +1.4%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,888.25 -0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,119.20 +1.3%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,210.75 +0.7%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,800.50 +1.9%
Cipla Ltd. Consolidated 2023-03 12.85 1,199.60 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,751.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,495.00 +1.4%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,888.25 -0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,119.20 +1.3%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,210.75 +0.7%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,800.50 +1.9%
Cipla Ltd. Consolidated 2023-03 12.85 1,199.60 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,751.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,495.00 +1.4%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,888.25 -0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,119.20 +1.3%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,210.75 +0.7%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,800.50 +1.9%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,199.60 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,751.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,495.00 +1.4%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,888.25 -0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,119.20 +1.3%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,210.75 +0.7%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,800.50 +1.9%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,199.60 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,751.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,495.00 +1.4%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,888.25 -0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,119.20 +1.3%

Unjha Formulations Ltd. FAQ's

What is Unjha Formulations share price?
Can I buy Unjha Formulations shares now?
What is the Market Cap of Unjha Formulations?
What are the key metrics to analyse Unjha Formulations?
What is the 52 Week High and Low of Unjha Formulations?
What is the trend of Unjha Formulations share price?